Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

LXR to commence pivotal trials with HK-Cardiosol

Nov. 10, 1997

Mechanism of action of triptolide investigated in human T-cells

Nov. 10, 1997

Confirmatory trials of Alpha-Beta's Betafectin to begin

Nov. 10, 1997

Merck to develop Vical technology for therapeutic vaccines

Nov. 7, 1997

Heat shock proteins: a new vaccine strategy

Nov. 6, 1997

New human rabies vaccine cleared in U.S.

Nov. 4, 1997

Novel class of compound enhances IFN-gamma and NT-3 activity

Nov. 4, 1997

ID Vaccine and the NIAID collaborate on GAS vaccine

Oct. 31, 1997

Gene therapy approach to preventing organ transplant complication explored

Oct. 29, 1997

VZIG study in postherpetic neuralgia stopped; chickenpox study continues

Oct. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...